BioSpace News Archive

Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company with a continuous delivery platform of approved drugs in novel indications, announced today Pedro Lichtinger, Chairman and CEO of Starton, will participate in the 20th Annual Needham Healthcare Conference,

Today, before the National Kidney Foundation’s 2021 Spring Clinicals Meetings of thousands of kidney health professionals, hundreds of studies from the last year were presented including three studies considered “late-breaking” research papers.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it will report first quarter 2021 financial results on Thursday, April 22, 2021, before the market opens

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on April 12 – 15, 2021.

NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced the filing of its universal registration document for the financial year ended December 31, 2020 with the French financial market authority (Autorité des marchés financiers or AMF),

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Trodelvy® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease

AcornMed Biotechnology Co., Ltd. announced that they will incorporate Twist Bioscience next generation sequencing target enrichment and library preparation panels into AcornMed’s portfolio of tests designed to provide insight into the genetic predisposition and treatment regimens for patients, providing a more targeted therapeutic approach.

PhaseBio Pharmaceuticals to Present at 20 th Annual Needham Virtual Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:45 a.m. Eastern Time.

Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 6,666,667 shares of common stock (or common stock equivalents in lieu thereof) of the Company at a price to the public of $1.50 per share (or common stock equivalent), less underwriting discounts and commissions.